Clinical Trial Update: Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study

View source ↗

Summary

A completed post-trial observational study follow-up of the Preterax and Diamicron MR controlled evaluation in people with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Diamicron MR (gliclazide MR)
• Preterax (perindopril erbuminate and indapamide)

Snippet

Sponsor: The George Institute | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED